Can a radiation boost help fight pancreatic cancer?
NCT ID NCT07242911
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether giving a higher dose of radiation (60-65 Gy) using a precise technique called VMAT can help people with inoperable pancreatic cancer live longer and keep their tumors under control compared to the standard lower dose (45-50.4 Gy). Researchers will follow 30 patients who already received VMAT as part of their care, tracking survival, tumor response, and side effects. The goal is to find a safer, more effective radiation approach for this hard-to-treat cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Volumetric Modulated Arc Therapy (VMAT) radiation
- What this could lead to
- If successful, this could show that a higher radiation dose improves survival and tumor shrinkage for people with inoperable pancreatic cancer.
- What could go wrong
- This is a small, early observational study, not a randomized trial. Results may not apply broadly, and higher radiation could increase side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PPANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chifeng Tumor Hospital
Chifeng, Inner Mongolia, 024000, China